Showing results (6481-6490 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 16, 2009
Studying the human gut microbiota in the trans-omics era--focus on metagenomics and metabonomicsKieran M Tuohy, Christos Gougoulias, Qing Shen, et al.Current Pharmaceutical Design|May 16, 2009
Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humansA R Lomax, P C CalderCurrent Pharmaceutical Design|May 16, 2009
The role of the gut microbiota in energy metabolism and metabolic diseasePatrice D Cani, Nathalie M DelzenneCurrent Pharmaceutical Design|May 16, 2009
Opiates as antidepressantsEsther Berrocoso, Pilar Sánchez-Blázquez, Javier Garzón, et al.Current Pharmaceutical Design|May 16, 2009
Endocannabinoids in the treatment of mood disorders: evidence from animal modelsFrancis Rodriguez Bambico, Andrea Duranti, Andrea Tontini, et al.Current Pharmaceutical Design|May 16, 2009
Melatonin receptor agonist agomelatine: a new drug for treating unipolar depressionMichel Bourin, Corina PricaCurrent Pharmaceutical Design|May 16, 2009
New approaches to antidepressant drug design: cytokine-regulated pathwaysAkira Nishida, Tsuyoshi Miyaoka, Takuji Inagaki, et al.Current Pharmaceutical Design|May 16, 2009
Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functionsMoran Golan, Gabriel Schreiber, Sofia AvissarCurrent Pharmaceutical Design|May 16, 2009
Neuropathic pain: models and mechanismsMichael F Jarvis, Janel M Boyce-RustayPageof 1,008